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RECENT DEVELOPMENT
DOE V. ALTERNATIVE MED. MD., LLC: GROWERS OF
MEDICAL CANNABIS WERE ENTITLED TO INTERVENE IN

AN ACTION REGARDING THE ISSUANCE OF GROWERS'
LICENSES BECAUSE THEIR MOTION WAS TIMELY AND
THEY SHOWED AN IMPEDIMENT TO AN INTEREST THAT
WAS NOT ALREADY ADEQUATLY REPRESENTED.
By: Marrio B. Davis
The Court of Appeals of Maryland held that certain pre-approved medical
cannabis growers were entitled to intervention as of right under Maryland
Rule § 2-214 ("Md. Rule § 2-214"). Doe v. Alternative Med. Md., LLC, 455
Md. 377, 168 A.3d 21 (2017). In compliance with Md. Rule § 2-214, the
growers' motion to intervene was timely, they had a clear interest in the case
not represented by the current parties, and they demonstrated an impediment
to that interest. Id. The court further held that the growers were entitled to
intervention under section 3-405 of the Courts and Judicial Proceedings of
the Maryland Code ("CJ §3-405"). Id. However, the court affirmed the
lower court's denial of the trade associations' and patients' motion for
intervention. Id.
The Maryland General Assembly created the Natalie M. LaPrade Medical
Cannabis Commission ("Commission") in 2013 to facilitate pre-approvals
and licensing procedures for medical cannabis growers in Maryland. In
August of 2016, the Commission pre-approved the top fifteen applications
for medical cannabis grower licenses. Alternative Medicine Maryland, LLC
("AMM"), an African-American owned business, was not one of the
applicants selected for a grower license.
AMM filed a complaint alleging that the Commission violated section 133306 of the Maryland Heath Code ("HG § 13-3306") by failing to consider
racial and ethnic diversity in their pre-approval process for medical cannabis
AMM additionally sought an order to prohibit the
grower licenses.
Commission from issuing final approvals on the fifteen pre-approved grower
licenses until the Commission complied with HG §13-3306. The court
ultimately granted AMM's request for a temporary restraining order and
preliminary injunction.
The Commission filed a motion to dismiss arguing that the pre-approved
growers were necessary parties which AMM failed to include as defendants.
Later, several businesses with pre-approved licenses and patients filed
motions to intervene. These parties contended that they had a direct interest
in the action which would be prejudiced by any delay. The circuit court
denied the motions to intervene and consequently, the motion to dismiss,
concluding that the interveners had not met their burden of showing
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intervention as of right. The growers filed a petition for a writ of certiorari
and a motion to stay the circuit court proceedings, which were granted.
The Court of Appeals of Maryland first examined whether the circuit
court erred in denying the growers' motion to intervene. Doe, 455 Md. at
419, 168 A.3d at 46. For intervention to be granted as of right the motion
must meet the following requirements: timeliness, party must claim an
interest related to the subject of the action, the disposition of the action must
impair or impede that person's ability to protect that interest, and the interest
is not already adequately represented by existing parties. Id. at 415, 168
A.3d at 44 (citing Maryland Rule 2-214(a)(2)).
In applying these requirements, the court examined four factors in its
determination of timeliness. Doe, 455 Md. at 420, 168 A.3d at 47. These
factors included the purpose for which the intervention was sought, the
probability of prejudice to the parties, the progression of the proceedings,
and the reasons for delaying intervention. Id. (citing Md. -Nat '1 CapitalPark
& Planning Comm'n v. Town of Washington Grove, 408 Md. 37, 70, 968
A.2d 552, 572 (2009)). Applying these factors, the court found that the
growers sought to intervene to protect their medical marijuana companies
which constituted a valid property interest. Doe, 455 Md. at 420, 168 A.3d
at 47. The interest in their companies would have been impeded by AMM's
requested order to withhold final approvals of their licenses. Id.
Furthermore, the motion to intervene was only filed two months after
AMM's complaint and AMM never raised the issue of untimeliness. Id.
Ultimately, the court concluded that the motion was filed in the appropriate
time and there was no delay in seeking intervention. Id.
The court continued to analyze intervention as of right by examining the
remaining requirements. Doe, 455 Md. at 415, 168 A.3d at 44. The growers
were required to show an interest essential to the case and not otherwise
protected by the existing parties. Id. Additionally, intervening parties are
required to establish that the disposition of the action would potentially
impair their ability to protect that interest. Id. at 416, 168 A.3d at 44 (citing
Washington Grove, 408 Md. at 99, 968 A.2d at 590). Thus, the growers
must demonstrate that they will be disadvantaged in some way by the case's
disposition. Doe, 455 Md. at 416, 168 A.3d at 44 (citing Bd. of Trs. Of
Emps.' Ret. Sys. of City of Balt. V Mayor & City Council of Balt. City, 317
Md. 72, 89 n. 19, 562 A.2d 720, 728 n.19 (1989)).
The court found the growers had a valid interest because they had already
begun hiring employees and contracting facilities to meet the state's
regulatory deadlines. Doe, 455 Md. at 421, 168 A.3d at 47. Costs
accumulated in anticipation of future business created a financial burden on
the growers. Id. Further, the court noted that because of the growers' preapproved status, they could be clearly disadvantaged since the disposition
could impact their current status in the licensing process. Id. at 422, 168
A.3d at 48. Therefore, the court concluded that exclusion of the growers as
parties would impede the growers' ability to protect their interests in the
licensing process. Id. at 423, 168 A.3d at 48.
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The court also found that the growers met the fourth requirement of
inadequate representation. Doe, 455 Md. at 423, 168 A.3d at 49. This
requires a comparison between the interests of the party seeking intervention
and those of the current parties. Id. at 417, 168 A.3d at 45 (citing
Washington Grove, 408 Md. at 102, 968 A.2d at 591). The court determined
that as competitors in the medical cannabis industry, the growers and AMM
had adverse interests. Doe, 455 Md. at 423, 168 A.3d at 49. Similarly, the
Commission also could not adequately represent the growers since their
interest was to license qualified growers, not to favor a particular grower
over another. Id. Therefore, the court found it impossible for AMM or the
Commission to adequately represent the growers' interests. Id. Having met
all the requirements of Md. Rule 2-214(a)(2), the growers were entitled to
intervene as of right. Id.
Next, the court moved to the issue of intervention as of right for the trade
association and select patients. Doe, 455 Md. at 430, 168 A.3d at 53. The
patients claimed a future interest since qualifying physicians may prescribe
them medical cannabis for their illnesses. Id. Additionally, the trade
association claimed an interest because of their advocacy for access to
medical cannabis. Id. The court found these interests too generalized and
not adequately related to the subject of the action. Id.
Although the trade associations' and patients' interests could be harmed,
the court could not determine with any degree of certainty that the outcome
of the suit would cause specialized damage different than that of the general
public. Doe, 455 Md. at 431, 168 A.3d at 53. The court also found that the
trade associations' and patients' interests could not be impaired or impeded
because the disposition of the case would not prevent medical cannabis from
becoming available in Maryland. Id. at 431, 168 A.3d at 54. Ultimately, the
court found the interests of the trade associations and patients too attenuated
to satisfy Md. Rule 2-214. Id. at 430, 168 A.3d at 53.
Finally, the court examined intervention claims brought in cases of
declaratory judgment. Doe, 455 Md. at 419, 168 A.3d at 46. Id. CJ § 3-405
provides an independent basis for intervention separate from Md. Rule § 2214 when declaratory judgment is at issue. Id. at 428-29, 168 A.3d at 51-2.
The court noted that CJ § 3-405 applies specifically to declaratory judgment
actions. Id. However, similar to Md. Rule §2-214, the movant needs to
show an interest affected by the decision. Id. Therefore, the growers
satisfied CJ § 3-405 by demonstrating a valid property interest that would be
affected by the court's granting of AMM's order prohibiting the growers
license approvals. Id. at 430, 168 A.3d at 53.
Ultimately, The Court of Appeals of Maryland concluded that the growers
were entitled to intervention as of right and remanded the case for further
proceedings. However, the trade associations and patients were not entitled
to intervention. This case clarifies the court of appeal's distinction between
interventions under CJ § 4-305 and Md. Rule § 2-214. Parties must only
demonstrate an interest in the case that could be impeded by the disposition.
The threshold for motions to intervene is rather low and should continue to
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allow interested parties to intervene without much issue. Further, the case
demonstrates the many parties with interests pertaining to the medical
cannabis industry. Allowing these parties to intervene will keep the industry
balanced and non-discriminatory.

